Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Anika Therapeutics ( (ANIK) ) just unveiled an announcement.
On November 5, 2025, Anika Therapeutics announced the filing of the third and final module of its Premarket Approval application for Hyalofast, a resorbable scaffold for treating knee cartilage defects, and released positive data from its U.S. Phase III clinical trial. The company reported a 6% decrease in third-quarter revenue compared to 2024, despite a 22% increase in Commercial Channel revenue and a significant milestone for Cingal, which surpassed one million injections globally. Anika also announced a $15 million share repurchase plan and reaffirmed its fiscal 2025 guidance, highlighting strong growth in its Integrity Implant System and international OA Pain Management.
The most recent analyst rating on (ANIK) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Anika Therapeutics stock, see the ANIK Stock Forecast page.
Spark’s Take on ANIK Stock
According to Spark, TipRanks’ AI Analyst, ANIK is a Neutral.
Anika Therapeutics’ overall stock score is primarily impacted by its financial performance, which is challenged by declining revenues, persistent losses, and cash flow difficulties. Technical analysis shows short-term positive trends but longer-term bearish momentum. Valuation is weak due to a negative P/E ratio and no dividend yield. The earnings call provided a mixed outlook, but it was not included in the weighted score due to the methodology.
To see Spark’s full report on ANIK stock, click here.
More about Anika Therapeutics
Anika Therapeutics, Inc. is a global leader in the design, development, manufacturing, and commercialization of hyaluronic acid innovations. The company focuses on osteoarthritis pain management and orthopedic regenerative solutions, aiming to improve patient outcomes worldwide. Anika’s global operations are headquartered outside of Boston, Massachusetts.
Average Trading Volume: 104,617
Technical Sentiment Signal: Sell
Current Market Cap: $138.8M
Find detailed analytics on ANIK stock on TipRanks’ Stock Analysis page.